×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
LS51 Next-Generation Digital Healthcare Considering Pre-Symptomatic State, Prevention, and Well-Being (Part 2)
Session Chair(s)
Takashi Moriya, PhD, MBA
Director, Vaccines, Real-World Evidence and Health Outcomes Research
GlaxoSmithKline K.K., Japan
Speaker(s)
Takeru Hiki
Welby Inc, Japan
CEO
Hiroyuki Idone
Novo Nordisk Pharma Ltd., Japan
Digital Health Program Lead
Have an account?